Loading clinical trials...
Loading clinical trials...
A Randomized, Triple-blind Placebo-controlled Single Center Trial to Evaluate the Immune Response to the Consumption of a Minidrink Containing a Combination of Lactobacillus GG and Fructooligosaccharides in Patients With Recurrent Herpes Labialis
Conditions
Interventions
Probiotics
Prebiotics
+2 more
Start Date
December 15, 2008
Primary Completion Date
September 16, 2009
Completion Date
October 20, 2009
Last Updated
October 12, 2017
NCT02965781
NCT03977792
NCT00306293
NCT03310294
NCT02207881
NCT01985321
Lead Sponsor
Sprim Advanced Life Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions